No new HIV infections seen in San Francisco's Strut PrEP programme
Efavirenz appears to be associated with elevated suicide risk in START trial
A detectable CMV viral load could signal a high risk of mortality in older individuals hospitalised with HIV-associated TB
People shifting from paediatric to adult HIV care have a high risk of ART failure
Package of prophylaxis against infections reduces the risk of death for people starting HIV treatment very late
Ending AIDS by 2030 a distant prospect, global HIV incidence, prevalence, treatment coverage and mortality figures suggest
AbbVie 3D and 2D hepatitis C combos work well for people with HIV and HCV co-infection
START analysis looks at who benefits most from immediate HIV treatment
